Nvidia’s stock gets a rare downgrade, as there are bigger problems than tariffs
While investors generally are worried about tariffs today, an HSBC analyst is more concerned about Nvidia’s pricing power and ...
US FDA approves Amgen's Uplizna as first treatment for rare immune disorder
The U.S. Food and Drug Administration has approved expanded use of Amgen's drug, Uplizna, to help reduce the risk of flares ...